Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONTO-Pump-2: LY900014 versus Humalog in adults with type 1 diabetes using insulin pump therapy
MOH_2019-02-19_005981Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing LY900014 with Humalog (2 arms). Primary endpoint: Change in HbA1c from baseline to week 16. Started Jan 2019; status: completed.
02
Drugs
insulin lisprohuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on MOH_2019-02-19_005981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-02-19_005981.